News Focus
News Focus
icon url

Investor082

02/02/25 4:42 PM

#747082 RE: XMaster2023 #747079

Nope, 15M annual revenue won’t be enough to cover one quarter of expense. The quarterly expense is $15M but that will go up to $30-40M per quarter with UK commercialization efforts and one additional clinical trial support.